Innovent Biopharmaceutical Technology
Organisation
Trials
Phase 2/3, Recruiting, 2026, 680 people, 24 Mar 2026, clinicaltrials.gov
Phase 3, Recruiting, 2026, 540 people, 30 Jan 2026, clinicaltrials.gov
Organisation
Phase 2/3, Recruiting, 2026, 680 people, 24 Mar 2026, clinicaltrials.gov
Phase 3, Recruiting, 2026, 540 people, 30 Jan 2026, clinicaltrials.gov